• Skip to main content
  • Skip to footer
  • Home
  • About
    • MyPE Copyright Terms
    • Authors
    • Deals
  • Info
    • Accommodation
    • Classified Adverts
    • Directory
    • Essential PE Numbers
    • Flight Schedules
    • Forex Converter
    • PE’s Online Radio Stations
      • Algoa FM
      • Bay FM
      • iFM
      • Kingfisher FM
      • MannMade Radio
      • Madibaz Radio
      • Umhlobo Wenene
    • Podcasts
    • Shipping
    • Street Map
    • Tides
    • Ward Details
    • Ward News
    • Weather
  • Contact
    • Advertising on MyPE
  • Submit
    • Blogger
    • 5 Quick PE Questions
    • Entertainment
    • Events
      • Add your Port Elizabeth event
    • Letter to the Editor
    • Lost and Found
    • Movers and Shakers
    • News Article
    • PE Videos
    • Photographs
    • Recipes
    • Traffic Hooligan
    • Say NO
  • Dam Levels
  • Advertorial
  • Business
  • NMBRA
  • NMB Rates
MyPE

MyPE

Community Business Directory, Event Listings, News and Views from Gqeberha, Nelson Mandela Bay

HIV Gel Reduces Infection by 39%

14 June 2011 By Alan Straton

After encouraging results on a vaginal gel containing the antiretroviral drug tenofovir, which reduces HIV infection and risk of contracting genital herpes, a follow-up study to test the safety of the gel has been launched.

Editors Notes: It now looks like women who bed condom averse men (so called members of the human race – sies, ga, ptooie!) will now at least have a better than zero chance of contracting HIV or herpes.

The Phase III trial, to be known as FACTS 001, will be conducted by the Follow-on African Consortium for Tenofovir Studies (FACTS) led by Professor Helen Rees, who is the Director of the Wits Reproductive Health and HIV Institute (WRHI). It is expected to start by the end of July and run for 24 months.

The study prior to this, known as CAPRISA 004, was conducted last year by the Centre for the Aids Programme of Research in South Africa (CAPRISA) on nearly 900 women in KwaZulu-Natal.

It showed that the use of the gel reduced HIV infection by 39 percent and also reduces the risk of contracting genital herpes by 51 percent.

However, CAPRISA 004 was a relatively small trial (Phase IIb trial) and was not designed for licensure purposes.

On Tuesday, the Department of Science and Technology, in partnership with the United States, launched FACTS 001, which will test the safety and effectiveness of 1 percent tenofovir gel.

FACTS 001 will be a bigger study than CAPRISA 004, involving 2 200 women aged 18 to 30 years at seven trial sites across South Africa.

Speaking at the launch of FACTS 001, Deputy Minister of Science and Technology, Derek Hanekom, said government was looking forward to this stage of the trial and was very proud of the collaboration between the South African government and United States of America.

He noted that while people should continue to condomise and be faithful, research for vaccines also have to continue, adding that once the results are positive and confirmed, it would make it possible to help protect women against HIV and Aids.

“This product does something different, it gives women the power to negotiate and make decisions for themselves. It needs to be done. We are ready and if it confirms its effectiveness, we will soon put it on the market, combined with the roll out of the treatment,” Hanekom said.

The department had funded the trial with an amount of R17 million for a three-year period.

Professor Rees said the research found that using the gel before and after sex provided moderate protection against HIV and Herpes Simplex.

“The establishment of the FACTS consortium to confirm the effectiveness of the first vaginal microbicide gel for women and enable licensure is extremely exciting for South African researchers. The objectives of the FACTS 001 confirm the CAPRISA 004 results in larger more diverse populations.

“The South African government’s support for FACTS demonstrates a new era of collaboration between researchers and government with the common vision of preventing HIV infections in women,” said Rees.

United States Ambassador Donald Gips commended the South African government for its decision to fund the FACTS study and partnering with the US, which has pledged to fund the study for R129 million for a three-year period.

“The study offers a new tool to prevent HIV and Aids. We have to figure out how to prevent more people from being infected with the disease. It is very urgent for the researchers to complete the trial for its approval because protecting women and girls from contracting the disease is very crucial,” Gips said.

“We are committed to empowering women and girls to protect themselves by finding new HIV prevention options. Confirming tenofovir gel’s effectiveness is a fundamental and essential step in the right direction. Together, government and civil society are making strides to slow down the infection, and the US is very proud to support you.”  – Gabi Khumalo, BuaNews

The following two tabs change content below.
  • Bio
  • Latest Posts
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Alan Straton

Chief Cook, Bottle Washer and Broom Mechanic at MyPE
Passionate about Port Elizabeth and definitely NOT packing for Perth. Alan's ethos is epitomised in the words of Nelson Mandela; "I have fought against white domination and I have fought against black domination. I have cherished the idea of a democratic and free society. If need be, it is an ideal for which I am prepared to die." See more articles by Alan.
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Latest posts by Alan Straton (see all)

  • Alu Door & Window Centre Readies Mpumalanga Homes for the Summer Storms - 30 September 2026
  • If AI Can Now Do the Work, Who Checks the Work? - 29 September 2026
  • UK Music Titans Marc Marot & Jeremy Marsh Join #MEX26 in Cape Town - 29 September 2026
  • The Countdown On – Mind Matters Is Taking Over Cape Town Before Taking the Conversation Global - 28 September 2026
  • BurnesSEO Study Finds South African Small Businesses Invisible in AI Search Results - 28 September 2026

Filed Under: Community Tagged With: aids, gel, herpes, hiv

Footer

RSS Straton Electrical

  • Open Cycle Gas Turbine Usage
  • Flattening the curve – What Every Solar Installer Needs to Know
  • Why you shouldn’t leave a charger plugged in when not in use
  • How do I check if an Electrician is properly registered in South Africa?
  • Easy Electrical Troubleshooting for Humans
  • Water – If You Cannot Measure It Then You Cannot Manage It
  • Tips To Survive Loadshedding
  • Eskom’s Top 50 Electricity Saving Tips

RSS MyPE Business News

  • NMBBC On Budget 2025
  • Leading Business Minds Set to Headline Chambers Annual General Meeting
  • Bay of Opportunity Portal
  • Bay of Opportunity Ambassadors Programme to Promote the Bay and Attract Investment
  • 6 Decades of Trucking
  • Thermal Camera Installed at Redhouse Substation
  • Finalist in the 2025 South African Car of the Year
  • Joining hands to create a lasting impact to St Albans Primary School

RSS MyPR Press Releases

  • AutoTrader Reports Softer August Sales as Average Used Car Price Falls
  • TechMarkit Market Analysis Identifies Key Factors Influencing Escalating Laptop Prices in South Africa
  • Broadway Sweets Publishes Industry Guidelines for Evaluating Wholesale Sweets Suppliers in South Africa
  • Metalcross Outlines the Timeline and Cost Implications of an Unrepaired Car Scratch
  • A Wild Family Adventure Awaits at Lion & Safari Park These School Holidays

How you may use MyPE content © 2026 MyPE · Gqeberha, South Africa | Privacy Policy | MyPE Ads and Media Kit